Clinical Trials Logo

IBS - Irritable Bowel Syndrome clinical trials

View clinical trials related to IBS - Irritable Bowel Syndrome.

Filter by:

NCT ID: NCT03555188 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial

TRITON
Start date: March 29, 2018
Phase: Phase 3
Study type: Interventional

A placebo controlled study to determine the efficacy and mode of action of ondansetron in the treatment of irritable bowel syndrome with diarrhoea.

NCT ID: NCT03492333 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

Gluten Free Diet in IBS Patients Stratified According to Their Antigliadin Status

GFD_IBS
Start date: April 30, 2012
Phase: N/A
Study type: Interventional

Gluten-free diet has been shown to improve gut symptoms in patients with celiac disease and also in adult patients with diagnosis of Irritable Bowel Syndrome (Rome III criteria). Antibodies to native gliadin (AGA) have been suggested as a potential diagnostic marker of response to GFD. However, this has not been tested in a prospective study in IBS patients. Identification of predictors of a symptomatic response to GFD within the IBS population would improve the clinical management of these patients. The purpose of this study is to evaluate the effect of gluten-free diet on gastrointestinal symptoms and gut motility in patients with Irritable Bowel Syndrome stratified according to their antigliadin antibodies status. Additional purposes include investigating effects gluten free diet may have on other parameters: - Improvement of mood - Quality of life and general well-being - Changes in gut microbiota

NCT ID: NCT03466281 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

Patient Education for Patients With Irritable Bowel Syndrome (IBS)

IBS
Start date: August 1, 2016
Phase: N/A
Study type: Interventional

In this randomized controlled study in patients with irritable bowel syndrome (IBS) the investigators plan to compare the effects of a structured patient group education (IBS School) with structured education provided via the internet. The effects of the interventions on GI and psychological symptom severity, knowledge and quality of life will be assessed with validated questionnaires at baseline, immediately after the intervention and 3 and 6 months after the intervention.

NCT ID: NCT03449628 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

L. Casei DG® in Patients With Irritable Bowel Syndrome.

PROBE2
Start date: November 6, 2017
Phase: N/A
Study type: Interventional

To assess the effect of L. casei DG® (Lactobacillus paracasei CNCMI1572; Enterolactis® plus) on abdominal symptoms and gut microbiota metabolism/composition in non constipated patients with IBS (Irritable Bowel Syndrome). Patients will be randomized to receive L. casei DG® capsules, b.i.d. for 12 weeks the a 4 weeks Follow Up period will follow.

NCT ID: NCT03432078 Active, not recruiting - Clinical trials for IBS - Irritable Bowel Syndrome

Individual vs. Group Hypnotherapy in Patients With Irritable Bowel Syndrome

Start date: August 15, 2011
Phase: N/A
Study type: Interventional

Patients' fulfilling Rome III criteria for IBS with symptoms refractory to standard treatment who are referred to a specialist unit for hypnotherapy are consecutively included in the study. The patients are randomized to either individual or group treatment given by a nurse trained in hypnotherapy. The treatment consists of eight sessions of gut directed hypno therapy during twelve weeks. Effects are measured by validated questionnaires at baseline and at various time points during the treatment period as well as after the completion of the treatment.

NCT ID: NCT03333291 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

Fecal Transplantation in Patients With IBS

Start date: October 1, 2016
Phase: N/A
Study type: Interventional

The study will characterize the biology of FMT in the context of IBS prior to wider clinical application of the method. Given the ethical concerns of unknown and long-term adverse effects of FMT therapy, the study will include patients only with moderate to severe symptoms. IBS is a heterogenous disorder and it is important to characterize the patients, and study as homogeneous patient populations as possible. Therefore the study will only include post-infectious IBS patients after the Giardia outbreak.

NCT ID: NCT03306381 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS

Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The aim of the present study is to research whether subjects with irritable bowel syndrome (IBS) display epigenetic/genetic changes or altered microbiota compared to a non-IBS control group. Further, we will investigate if these parameters as well as subjective IBS symptoms are affected by a 4-week long dietary intervention within the IBS patient group.

NCT ID: NCT03178877 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors

IBS
Start date: November 1, 2016
Phase: N/A
Study type: Observational [Patient Registry]

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects.

NCT ID: NCT03131414 Recruiting - Healthy Clinical Trials

The IMAGINE-SPOR CIHR Chronic Disease Network

IMAGINE
Start date: October 1, 2017
Phase:
Study type: Observational [Patient Registry]

The IMAGINE Cohort Study will identify and recruit a cohort of 8000 patients with IBS, IBD and healthy controls (2000 of each) who will be assessed in terms of their psychological status, dietary intake, gut microbiome, metabolomic and inflammatory markers and genotype, health-related quality of life, and health care resource use and associated costs. The cohort and healthy controls will be followed prospectively for up to 5 years after the completion of study enrolment.

NCT ID: NCT03019861 Completed - Clinical trials for IBS - Irritable Bowel Syndrome

Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional Counseling

AYURDA
Start date: January 2017
Phase: N/A
Study type: Interventional

The main goal of this randomized controlled clinical study is to evaluate the efficacy of an individual Ayurvedic nutritional counseling (according to tradition) compared to an individual conventional dietary advice (according to the German Nutrition Society - DGE) in patients with irritable bowel syndrome. It is to be investigated whether nutritional therapy elements, which patients can self-implement independently in the home environment, can achieve sustainable therapy effects.